e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Cardiovascular complications in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
M. Ruis, I. Mikulic, F. Tichelmann, O. C. Burghuber, A. Valipour (Vienna, Austria)
Source:
Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Session:
Cardiovascular complications in obstructive sleep apnoea
Session type:
Thematic Poster Session
Number:
826
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ruis, I. Mikulic, F. Tichelmann, O. C. Burghuber, A. Valipour (Vienna, Austria). Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea. Eur Respir J 2008; 32: Suppl. 52, 826
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Investigation of various factors in obstructive sleep apnea syndrome patients
Source: Eur Respir J 2006; 28: Suppl. 50, 194s
Year: 2006
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019
The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
The impact of obstructive sleep apnea syndrome on cardiovascular system in children
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001
The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome
Source: Eur Respir J 2009; 33: 233-236
Year: 2009
Treatment control in risk patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 411s
Year: 2006
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Risk factors of hypercapnia in patient with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept